2fcx: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="2fcx" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fcx, resolution 2.00Å" /> '''HIV-1 DIS kissing-l... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2fcx.gif|left|200px]]<br /> | [[Image:2fcx.gif|left|200px]]<br /><applet load="2fcx" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2fcx" size=" | |||
caption="2fcx, resolution 2.00Å" /> | caption="2fcx, resolution 2.00Å" /> | ||
'''HIV-1 DIS kissing-loop in complex with neamine'''<br /> | '''HIV-1 DIS kissing-loop in complex with neamine'''<br /> | ||
==Overview== | ==Overview== | ||
The kissing-loop complex that initiates dimerization of genomic RNA is | The kissing-loop complex that initiates dimerization of genomic RNA is crucial for Human Immunodeficiency Virus Type 1 (HIV-1) replication. We showed that owing to its strong similitude with the bacterial ribosomal A site it can be targeted by aminoglycosides. Here, we present its crystal structure in complex with neamine, ribostamycin, neomycin and lividomycin. These structures explain the specificity for 4,5-disubstituted 2-deoxystreptamine (DOS) derivatives and for subtype A and subtype F kissing-loop complexes, and provide a strong basis for rational drug design. As a consequence of the different topologies of the kissing-loop complex and the A site, these aminoglycosides establish more contacts with HIV-1 RNA than with 16S RNA. Together with biochemical experiments, they showed that while rings I, II and III confer binding specificity, rings IV and V are important for affinity. Binding of neomycin, paromomycin and lividomycin strongly stabilized the kissing-loop complex by bridging the two HIV-1 RNA molecules. Furthermore, in situ footprinting showed that the dimerization initiation site (DIS) of HIV-1 genomic RNA could be targeted by these aminoglycosides in infected cells and virions, demonstrating its accessibility. | ||
==About this Structure== | ==About this Structure== | ||
2FCX is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with K, CL and XXX as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | 2FCX is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=K:'>K</scene>, <scene name='pdbligand=CL:'>CL</scene> and <scene name='pdbligand=XXX:'>XXX</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FCX OCA]. | ||
==Reference== | ==Reference== | ||
| Line 16: | Line 15: | ||
[[Category: Ennifar, E.]] | [[Category: Ennifar, E.]] | ||
[[Category: Marquet, R.]] | [[Category: Marquet, R.]] | ||
[[Category: Paillart, J | [[Category: Paillart, J C.]] | ||
[[Category: CL]] | [[Category: CL]] | ||
[[Category: K]] | [[Category: K]] | ||
| Line 25: | Line 24: | ||
[[Category: rna]] | [[Category: rna]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:20:05 2008'' | ||